{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:24:27Z","timestamp":1787775867334,"version":"build-2784847793"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.4103\/2045-9912.254641","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T03:25:36Z","timestamp":1553052336000},"page":"52-53","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacogenomics of inhalational anesthetic agents"],"prefix":"10.4103","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-0301","authenticated-orcid":false,"given":"Abhijit S.","family":"Nair","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"R1-20250925","first-page":"393","article-title":"Implications of pharmacogenomics for anesthesia providers","volume":"78","author":"Ama","year":"2010","journal-title":"AANA J"},{"key":"R2-20250925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/bja\/aep130","article-title":"Pharmacogenomic variability and anaesthesia","volume":"103","author":"Searle","year":"2009","journal-title":"Br J Anaesth"},{"key":"R3-20250925","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.anclin.2017.01.014","article-title":"Pharmacogenomics in anesthesia","volume":"35","author":"Saba","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"R4-20250925","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.apha.2018.04.004","article-title":"Pharmacogenetics in pain treatment","volume":"83","author":"Peir\u00f3","year":"2018","journal-title":"Adv Pharmacol"},{"key":"R5-20250925","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1517\/14656566.8.14.2235","article-title":"The pharmacogenetics of analgesia","volume":"8","author":"Stamer","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"R6-20250925","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amsu.2015.11.001","article-title":"Pharmacogenetics and anaesthetic drugs: Implications for perioperative practice","volume":"4","author":"Behrooz","year":"2015","journal-title":"Ann Med Surg (Lond)"},{"key":"R7-20250925","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2344\/0003-3006-59.4.154","article-title":"Environmental implications of anesthetic gases","volume":"59","author":"Yasny","year":"2012","journal-title":"Anesth Prog"},{"key":"R8-20250925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/ACO.0b013e3283556129","article-title":"Pharmacogenetics in perioperative medicine","volume":"25","author":"Cohen","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"R9-20250925","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4097\/kjae.2011.60.2.73","article-title":"Mechanism of emergence agitation induced by sevoflurane anesthesia","volume":"60","author":"Kim","year":"2011","journal-title":"Korean J Anesthesiol"},{"key":"R10-20250925","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4097\/kjae.2008.55.2.139","article-title":"The influence of GABA A g2 genetic polymorphism on the emergence agitation induced by sevoflurane","volume":"55","author":"Park","year":"2008","journal-title":"Korean J Anesthesiol"},{"key":"R11-20250925","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000542-200408000-00006","article-title":"Anesthetic requirement is increased in redheads","volume":"101","author":"Liem","year":"2004","journal-title":"Anesthesiology"},{"key":"R12-20250925","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jopan.2017.04.008","article-title":"Malignant hyperthermia: a review","volume":"33","author":"Mullins","year":"2018","journal-title":"J Perianesth Nurs"},{"key":"R13-20250925","first-page":"355","article-title":"Management of malignant hyperthermia: diagnosis and treatment","volume":"10","author":"Schneiderbanger","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"R14-20250925","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1186\/1471-2253-14-S1-A7","article-title":"Dantrolene in the treatment of malignant hyperthermia: a case report","volume":"14","author":"Islander","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"R15-20250925","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"}],"container-title":["Medical Gas Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01612956-201909010-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:44:13Z","timestamp":1787773453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01612956-201909010-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/2045-9912.254641","relation":{},"ISSN":["2045-9912"],"issn-type":[{"value":"2045-9912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"2019-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}